CIK 0000879407
- Large accelerated filer
ARROWHEAD PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- ARWR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460408024
- Phone
- +1 626-696-4702
- Business address
- 177 E COLORADO BLVD, SUITE 700, PASADENA, CA, 91105
- Former names
- ARROWHEAD RESEARCH CORP, INTERACTIVE GROUP INC, INTERACTIVE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 48 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-01-07 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −8,000 | $19.70 | $158K | 465,433 |
| 2025-01-07 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −10,000 | $19.69 | $197K | 455,433 |
| 2025-01-06 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −17,765 | $19.68 | $350K | 482,835 |
| 2025-01-06 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −9,402 | $20.10 | $189K | 473,433 |
| 2025-01-04 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award 10b5-1 | +100,000 | 500,600 | ||
| 2024-03-06 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −40,000 | $35.19 | $1.4M | 400,600 |
| 2024-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −1,400 | $34.04 | $48K | 455,304 |
| 2024-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −5,800 | $34.97 | $203K | 449,504 |
| 2024-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale 10b5-1 | −8,904 | $35.65 | $317K | 440,600 |
| 2024-01-04 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award 10b5-1 | +75,000 | 456,704 | ||
| 2023-06-27 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −15,000 | $36.20 | $543K | 381,704 |
| 2023-01-04 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award | +60,000 | 396,704 | ||
| 2022-12-29 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −30,625 | $40.00 | $1.2M | 336,704 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −15,908 | $60.50 | $962K | 488,097 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −16,528 | $62.00 | $1.0M | 471,569 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −3,778 | $63.17 | $239K | 467,791 |
| 2022-01-05 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −3,786 | $63.95 | $242K | 464,005 |
| 2022-01-01 | Myszkowski Kenneth Allen Chief Financial Officer | Grant or award | +60,000 | 504,005 | ||
| 2021-01-12 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −1,441 | $81.00 | $117K | 444,005 |
| 2021-01-11 | Myszkowski Kenneth Allen Chief Financial Officer | Sale | −11,597 | $81.02 | $940K | 445,446 |
Page 1 of 7 · 128 trades